UNSPSC 51452102: Nitroxinil or nitroxynil

This classification denotes an antihelminthic agent with the molecular formula C7H3IN2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9L0EXQ7125, chemically known as benzonitrile, 4-hydroxy-3-iodo-5-nitro- but generally known as nitroxinil, which bears US NIH Compound Identifier 15532. European Medicines Agency schedules Nitroxinil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09330MIG. The term NITROXINIL is an International Non-Proprietary Name.

NITROXINIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Nitroxinil or nitroxynil bears US NLM identifiers UMLS ID C0028217 and NCI Concept Code C75227. SMILES: C1=C(C=C(C(=C1[N+](=O)[O-])O)I)C#N.

UNSPSC 51452102 Nitroxinil or nitroxynil is a Commodity code under which state and local governments procure specialized pharmaceutical and medical products, though recent opportunities show minimal activity tagged directly to this code. The two recent opportunities on record diverge sharply from the code's nominal scope: the Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets (neither nitroxinil products), and Seminole County, Florida released an IFB in June 2026 for Naloxone and Safe Drug Deactivation Systems (opioid-overdose treatment and harm-reduction equipment, again unrelated to the code's stated scope). Both opportunities reflect state health departments and county health agencies as the primary issuing bodies, with competitive bidding processes (IFB and award-based selection) and terms running 12 to 36 months inclusive of renewal periods.

The code shows activity concentrated in Florida and Illinois based on the recent record. The Seminole County opportunity required quarterly deliveries to a single county health facility in Sanford, Florida, with vendor responsibility for all shipping and delivery costs, while the Illinois Department of Public Health procurement was administered through a cooperative purchasing vehicle (MMCAP Infuse consortium). Neither opportunity specified set-asides or domestic-product preferences. The mismatch between the code's nominal definition and the actual products being procured under it — antibiotic tablets and opioid-antagonist systems rather than nitroxinil — suggests this code sees little procurement activity aligned to its stated pharmaceutical scope, and business development professionals should verify code alignment directly with issuing agencies before pursuing opportunities tagged to 51452102.